Proteome gets ISO certification for Frankfurt plant
Proteome Sciences, a UK specialist in protein biomarker and isobaric mass tagging contract services, has received ISO 9001:2008 certification for its R&D and production facilities in Frankfurt, Germany.
The Frankfurt facility was specifically designed to deliver a growing product line of isobaric Tandem Mass Tags for quantitative mass spectrometry and to undertake biomarker programs for customers.
Proteome says it now provides a comprehensive range of contract biomarker services under ISO 9001: 2008 for discovery and validation of protein and peptide biomarkers, for rapid development of mass spectrometry-based assays and for the measurement of protein and peptide drugs and their metabolites in pharmacokinetics.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze